ARN22089 is a oral active novel class of trisubstituted pyrimidine, blocks the interaction of CDC42 GTPases with specific downstream effectors. ARN22089 blocks tumor growth in BRAF mutant mouse melanoma model[1].
Molecular Weight:
373.49
Purity:
98.73
CAS Number:
[2248691-29-2]
Formula:
C23H27N5
Target:
Ras
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted